508 results on '"Schoot, C. E."'
Search Results
2. Vox Sanguinis International Forum on application of fetal blood grouping: summary
3. RHD genotype and zygosity analysis in the Chinese Southern Han D+, D− and D variant donors using the multiplex ligation‐dependent probe amplification assay
4. Detection and Quantification of Minimal Residual Disease in Childhood B-Precursor Acute Lymphoblastic Leukemia by Limiting Dilution and PCR Application
5. Analysis of false-positive results of fetal RHD typing in a national screening program reveals vanishing twins as potential cause for discrepancy
6. Haemolytic disease of the fetus and newborn
7. Non-invasive prenatal diagnosis – erythrocyte and platelet antigens
8. Acute Leukemias of Different Lineages Have Similar MLL Gene Fusions Encoding Related Chimeric Proteins Resulting from Chromosomal Translocation
9. Improved flow cytometric detection of minimal residual disease in childhood acute lymphoblastic leukemia
10. Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia
11. Degradation of radioiodinated B cell monoclonal antibodies: inhibition via a FCγ -receptor-II-mediated mechanism and by drugs
12. LOW ANTI-RHD IGG-FC-FUCOSYLATION IN PREGNANCY: A NEW VARIABLE PREDICTING SEVERITY IN HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN: 4D-S38-04
13. PROPHYLACTIC ANTI-D BATCHES DISPLAY VARIABLE DECREASE IN FC-FUCOSYLATION, AFFECTING BINDING TO FCγRIIIA AND CLEARANCE RATE OF RBC: 4D-S38-03
14. C-REACTIVE PROTEIN BOOSTS ANTIBODY-MEDIATED PLATELET DESTRUCTION: 4C-S33-04
15. TECHNICAL PERFORMANCE OF THE FULLY AUTOMATED FETAL RHD SCREENING PROGRAM IN THE NETHERLANDS: 4A-S25-05
16. CAN CHIMERISM CAUSE FALSE POSITIVE RESULTS IN NON-INVASIVE BLOOD GROUP GENOTYPING?: 4A-S25-04
17. GENETIC SCREENING FOR THE VEL-PHENOTYPE CIRCUMVENTS DIFFICULT SEROLOGICAL SCREENING DUE TO VARIABLE VEL EXPRESSION LEVELS: 2C-S10-03
18. Gene expression profile of slowly responding subclones might represent different profiles already at diagnosis and might be used for prediction of outcome
19. Transplantation of human peripheral blood CD34-positive cells in combination with ex vivo generated megakaryocytes results in fast platelet formation in NOD/SCID mice
20. Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data
21. Nieuwe technieken in de obstetrie: detectie van foetaal dna in maternaal bloed
22. COMPREHENSIVE GENOTYPING FOR 18 BLOOD GROUP SYSTEMS USING MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION (MLPA): 4A-S34-02
23. THE IMMUNE RESPONSE TO THE VEL ANTIGEN IS HLACLASS II DRB1*11 RESTRICTED: 2D-S13-02
24. MOLECULAR RHD VARIATION OF SEROLOGICAL RHDNEGATIVE WOMEN: IMPLICATIONS FOR A FETAL RHD SCREENING PROGRAMME TO TARGET ANTI-D PROPHYLAXIS: 2C-S08-02
25. A DIFFERENT BALANCE IN WNT-SIGNALING IN ADULT AND FETAL BONE MARROW-DERIVED MSC: 2A-S04-03
26. A PROMINENT LACK OF IGG1 FC-FUCOSYLATION OF PLATELET-ALLOANTIBODIES IN PREGNANCY: 2A-S03-05
27. PRENATAL SCREENING: 1A-H01-02
28. A nation-wide fetal RHD screening programme for targeted antenatal and postnatal anti-D
29. NONINVASIVE PRENATAL SCREENING FOR RHD IN THE NETHERLANDS: ONE TEST FOR TARGETED ANTENATAL AND POSTNATAL ANTI-D PROPHYLAXIS: 4C-S25–02
30. HIGH-THROUGHPUT RED BLOOD CELL ANTIGEN GENOTYPING IN CHINESE DONORS USING IDCORE+ AND MLPA ASSAY: 4D-S18–04
31. Report of the Fourth International Workshop on molecular blood group genotyping
32. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience
33. Noninvasive fetal genotyping of human platelet antigen-1a
34. PERFORMANCE OF TWO NEW METHODS FOR HIGH-THROUGHPUT GENOTYPING OF BLOOD GROUPANTIGENS: IDCORE+ AND MLPA: 4D-S21–03
35. FETAL BLOOD GROUP GENOTYPING: 2B-E1.4
36. Prevalence of JAK2V617F mutation in women with unexplained recurrent miscarriage
37. Non-invasive fetal blood typing for platelet and red cell antigens: No.33
38. Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review
39. Blood group genotyping: from patient to high-throughput donor screening
40. Report of the Third International Workshop on Molecular Blood Group Genotyping
41. Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnancy
42. Genotyping for red blood cell polymorphisms
43. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands
44. Report of the Second International Workshop on molecular blood group genotyping
45. International Society of Blood Transfusion Committee on Terminology for Red Cell Surface Antigens: Cape Town report
46. High-Throughput Genotyping for Red Cell and Platelet Blood Group Antigens by DNA Micro Arrays: SI07
47. RISK FACTORS FOR RHESUS-D-IMMUNIZATION DESPITE POST-AND ANTENATAL ANTI-D-PROPHYLAXIS: P-293
48. PREDICTIVE VALUE AND SENSITIVITY OF FIRST TRIMESTER SCREENING FOR IRREGULAR ERYTHROCYTE ANTIBODIES TO DETECT NON-RHESUS-D-IEA-MEDIATED HAEMOLYTIC DISEASE OF THE NEWBORN IN THE NETHERLANDS: P-292
49. CLINICAL RELEVANCE OF NON-RHESUS-D-IEA TITER AND MONOCYTE-DRIVEN ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY TEST RESULT FOR THE PREDICTION OF SEVERE HAEMOLYTIC DISEASE OF THE NEWBORN.: P-287
50. NON-INVASIVE FETAL RHD GENOTYPING AND FETAL SEXING IN MATERNAL BLOOD: P-288
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.